What is letrozole IP 2.5 mg used for?
Letrozole tablets (including a 2.5 mg strength) are used to treat certain hormone-sensitive cancers, most commonly breast cancer in people who are postmenopausal. Letrozole belongs to a drug class called aromatase inhibitors. It lowers estrogen levels in the body, which can slow the growth of estrogen-receptor (ER)–positive tumors.
It’s also used in some cases of advanced or metastatic breast cancer and may be given as adjuvant (after surgery) therapy to reduce the risk of cancer returning, depending on the patient’s situation and ER status.
How does letrozole 2.5 mg work?
Letrozole reduces estrogen production by blocking the aromatase enzyme. Since many breast cancers grow in response to estrogen, lowering estrogen can help control or prevent tumor growth.
What are the common tablet indications doctors prescribe?
Common uses depend on the cancer stage and menopausal status, but letrozole 2.5 mg is typically prescribed for:
- Early-stage (adjuvant) hormone-receptor–positive breast cancer after initial treatment
- Advanced breast cancer (locally advanced or metastatic) in postmenopausal patients
- Hormone therapy for tumors that are ER-positive (and sometimes as guided by treatment history)
How is it usually taken?
A typical regimen for letrozole is once daily. The exact schedule (and how long to continue) depends on the cancer type, stage, and whether it’s being used after surgery or for advanced disease.
What side effects do patients commonly ask about?
People taking letrozole often report side effects related to lower estrogen, such as:
- Hot flashes
- Joint or muscle pain (arthralgia/myalgia)
- Tiredness
- Headache
- Vaginal dryness or dryness-related discomfort
Because estrogen also helps maintain bone density, long-term use can increase bone thinning (osteoporosis) risk, so clinicians may monitor bone health.
What precautions matter most?
Key precautions often include:
- Bone health: doctors may check bone density and may recommend calcium/vitamin D or other bone-protective steps if needed.
- Menopause status: letrozole is generally used in postmenopausal patients for breast cancer indications.
- Drug interactions and medical history: inform your clinician about other medicines and any history of bone disease or fractures.
If you tell me whether this is for breast cancer (and whether it’s early-stage or advanced/metastatic), plus the patient’s age/menopausal status, I can narrow the uses more precisely.